Pertussis acellular vaccine - BioNet Asia/Mahidol University
Alternative Names: Pertagen; Viaskin® rPT; Viaskin®-PTLatest Information Update: 05 Aug 2024
At a glance
- Originator BioNet-Asia; Mahidol University
- Developer BioNet-Asia; DBV Technologies; University of Geneva
- Class Bacterial vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pertussis